As of April 2024 Samsung Biologics has a market cap of $40.85 Billion. This makes Samsung Biologics the world's 468th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $40.85 B | -2.22% |
2023 | $41.77 B | -9.3% |
2022 | $46.06 B | -8.26% |
2021 | $50.21 B | -0.18% |
2020 | $50.30 B | 103.04% |
2019 | $24.77 B | 8.15% |
2018 | $22.90 B | -0.19% |
2017 | $22.95 B | 176.89% |
2016 | $8.28 B |
On Apr 22nd, 2024 the market cap of Samsung Biologics was reported to be: